FAP: The Next Billion Dollar Nuclear Theranostics Target?

被引：73
作者：
Calais, Jeremie [1 ,2 ,3 ,4 ]
机构：
[1] Univ Calif Los Angeles, Ahmanson Translat Theranost Div, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Phys & Biol Med Interdept Grad Program, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, Inst Urol Oncol, Los Angeles, CA 90095 USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2020年 / 61卷 / 02期
关键词：
BARRIERS;
D O I：
10.2967/jnumed.119.241232
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
[No abstract available]
引用
收藏
页码：163 / 165
页数：3
相关论文
共 30 条
[1]   Turning foes to friends: targeting cancer-associated fibroblasts [J].
Chen, Xueman ;
Song, Erwei .
NATURE REVIEWS DRUG DISCOVERY, 2019, 18 (02) :99-115
[2]   Inflammatory response in cervical intraepithelial neoplasia and squamous cell carcinoma of the uterine cervix [J].
Davidson, B ;
Goldberg, I ;
Kopolovic, J .
PATHOLOGY RESEARCH AND PRACTICE, 1997, 193 (07) :491-495
[3]   CELL-SURFACE GLYCOPROTEIN OF REACTIVE STROMAL FIBROBLASTS AS A POTENTIAL ANTIBODY TARGET IN HUMAN EPITHELIAL CANCERS [J].
GARINCHESA, P ;
OLD, LJ ;
RETTIG, WJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (18) :7235-7239
[4]  
Giesel FL, 2019, EUR J NUCL MED MOL I, V46, pS700
[5]   68Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers [J].
Giesel, Frederik L. ;
Kratochwil, Clemens ;
Lindner, Thomas ;
Marschalek, Manfred M. ;
Loktev, Anastasia ;
Lehnert, Wencke ;
Debus, Juergen ;
Jaeger, Dirk ;
Flechsig, Paul ;
Altmann, Annette ;
Mier, Walter ;
Haberkorn, Uwe .
JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (03) :386-392
[6]   Understanding fibroblast activation protein (FAP): Substrates, activities, expression and targeting for cancer therapy [J].
Hamson, Elizabeth J. ;
Keane, Fiona M. ;
Tholen, Stefan ;
Schilling, Oliver ;
Gorrell, Mark D. .
PROTEOMICS CLINICAL APPLICATIONS, 2014, 8 (5-6) :454-463
[7]   [177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study [J].
Hofman, Michael S. ;
Violet, John ;
Hicks, Rodney J. ;
Ferdinandus, Justin ;
Thang, Sue Ping ;
Akhurst, Tim ;
Iravani, Amir ;
Kong, Grace ;
Kumar, Aravind Ravi ;
Murphy, Declan G. ;
Eu, Peter ;
Jackson, Price ;
Scalzo, Mark ;
Williams, Scott G. ;
Sandhu, Shahneen .
LANCET ONCOLOGY, 2018, 19 (06) :825-833
[8]  
KELLY J, 2019, J NUCL MED S1, V60
[9]  
Khreish F, 2019, EUR J NUCL MED MOL I, P1
[10]   68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer [J].
Kratochwil, Clemens ;
Flechsig, Paul ;
Lindner, Thomas ;
Abderrahim, Labidi ;
Altmann, Annette ;
Mier, Walter ;
Adeberg, Sebastian ;
Rathke, Hendrik ;
Roehrich, Manuel ;
Winter, Hauke ;
Plinkert, Peter K. ;
Marme, Frederik ;
Lang, Matthias ;
Kauczor, Hans-Ulrich ;
Jaeger, Dirk ;
Debus, Juergen ;
Haberkorn, Uwe ;
Giesel, Frederik L. .
JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (06) :801-805
123